ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,637.00
-3.50 (-0.21%)
Last Updated: 11:45:20
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.50 -0.21% 1,637.00 1,636.50 1,637.00 1,647.00 1,634.00 1,638.50 609,050 11:45:20
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.70 67.5B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.50 billion. Gsk has a price to earnings ratio (PE ratio) of 13.70.

Gsk Share Discussion Threads

Showing 13476 to 13489 of 33100 messages
Chat Pages: Latest  544  543  542  541  540  539  538  537  536  535  534  533  Older
DateSubjectAuthorDiscuss
06/12/2016
09:12
38?, that is atypical so may be following a different disease progression.
essentialinvestor
06/12/2016
09:07
Friend of mine was diagnosed at 38. His son is my sons best friend - that was 6 years ago. He has been taking some new therapy and is doing ok. Even now you wouldn't really know - perhaps it's the therapy or more likely the progress is fortunately slow in him. Either way his kids teenage years are going to be hard.
dr biotech
06/12/2016
08:40
The lack of progress on dementia/AD research is incredibly depressing.

We look a decade away from anything effective.

essentialinvestor
06/12/2016
08:25
Not today. Think the low growth high yielding stocks will b under the cash for a while. Trumps stayed policies of lower taxation and higher spending will likely lead to increased inflation and that's not good for the dollar,bonds or stocks that act like bonds.
dr biotech
06/12/2016
07:02
When will we have a day this stays blue and closes up
mj19
05/12/2016
22:45
f880gna

"Good grief. I see that 30+ plus years of public education about HIV has yet to penetrate the thickest skulls."

Be clearer with your point missure.

minerve
05/12/2016
22:32
Good grief. I see that 30+ plus years of public education about HIV has yet to penetrate the thickest skulls.
f880gna
05/12/2016
20:41
"The cold economics would be what is the cost of preventing the spread or HIV compared to the cost of treating someone that is infected?"

What are the numbers?

Cost of treatment per person,for rest of their life in UK?

Fatality rates without treatment,

Percentage of UK's populace affected,

Percentage of world's population infected that subsequently cheats its way into UK to get expensive treatment.

Cancer is a bigger concern isn't it?

If it means run of the mill operations get cancelled for people who've paid into the pot their whole lives, that is wrong.If we can afford it,after all other operations/treatments that are required - fine. But as you know many cancer patients have to go without.Why should HIV patients get priority ahead of Cancer patients.

If you think NHS can continue in its current form you;re misguided.

Think we can borrow more and borrow? As national debt approache £1.78 trillion on balance sheet(off balance sheet who knows) at some point this excessive borrowing will not be an option.

At some point seniment is going to change..and then it'll get nasty fast.

Personally I'd be introducing some form of insurance. The NHS cant afford to carry on as it is.Nor can the country frankly.

fangorn2
05/12/2016
20:32
Fangorn

The cold economics would be what is the cost of preventing the spread or HIV compared to the cost of treating someone that is infected? a few years of one treatment compared to a lifetime of another? Plus less infections overall is a lower cost.

Also with HIV how are you going to tell who got it by having a risky lifestyle and how got it by misfortune? Could say the same about some cancers too.

dr biotech
05/12/2016
20:18
Diverse views make a democracy, if we all thought the same way
life would be very dull.

If PREP is rolled out following the 3 year trial GSK should be in pole
position for that contract, provided cabotegravir is successful in phase 111.

essentialinvestor
05/12/2016
17:34
There we go! "Religious inspired bigotry", "homophobic", all the usual words and soundbites we commonly hear because we don't accept the promotion of a decadent fad.
minerve
05/12/2016
15:34
I sold some of these before the US election. Of course I should have sold more than I did, but I am thinking of getting more. Question is when does the knife stop?
dr biotech
05/12/2016
15:19
Ahh - religious inspired bigotry, can't beat it.
dr biotech
05/12/2016
12:56
Sounds to me that you are just homophobic. Either we tackle all ills or none at all. What about other STDs? presumably we shouldn't treat any of these either?
dr biotech
Chat Pages: Latest  544  543  542  541  540  539  538  537  536  535  534  533  Older

Your Recent History

Delayed Upgrade Clock